Sartorius Stedim Biotech S.A.
Stock Details
Is it expensive?
Market Cap
17.40B
Trailing P/E Ratio
64.82
Forward P/E Ratio
29.56
PEG Ratio
29.56
19.91B
25.21
Price-to-Sales (TTM)
5.83
4.22
42.44
Is it profitable?
2.98B
Net Profit Margin (TTM)
8.98%
Gross Profit Margin
45.36%
Diluted EPS (TTM)
2.76
6.59%
Is it growing?
2.30%
2.90%
Is it risky?
1.13
63.11
2.61B
1.03
Who owns it?
12.13%
71.50%
0.00%
97.28M
27.60M
Does it pay?
1.54%
25.00%
Mar 31, 2026
--
How much cash?
521.20M
765.70M
256.06M
5.38
- Price (EOD)
- 178.90
- Percent Change
- -4.80 (2.61%)
- Previous Close
- 183.70
- Open
- 183.00
- Low
- 178.40
- High
- 184.90
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€178.90
From 52W Low
+19.27%
From 52W High
-20.13%
Today
-2.61%
1Y Change
-7.71%
6M
€213.30
3M
€170.15
1M
€167.20
Today
€178.90
From 52W Low
+19.27%
From 52W High
-20.13%
Today
-2.61%
1Y Change
-7.71%
6M
€213.30
3M
€170.15
1M
€167.20
Today
€178.90
Below Average
within its 1-year price range
€178.90
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+7.0%
3M
+5.1%
6M
-16.1%
1Y
-7.7%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Sartorius Stedim Biotech S.A.
- Founded
- 1978
- CEO
- Rene Faber
- Employees
- 10,456
- Fiscal Year End
- Dec 31, 2025
- Address
Zone Industrielle Les Paluds
Aubagne
MI
13781
France
- GICS Classification
- Health Care›Health Care Equipment & Services›Health Care Equipment & Supplies
- Website
- www.sartorius.com
Indicators
Operating Cash Flow
765.70M
Net Income
268.10M
Real Earnings
2.86
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Related Heatmaps
CAC Next 20Index CAC Next 20 - CN20 |
SBF 120Index SBF 120 - PX4 |
Indicators
Operating Cash Flow
765.70M
Net Income
268.10M
Real Earnings
2.86
Cash flow exceeds reported profit. Every dollar of profit is backed by actual cash. Only the most financially disciplined businesses consistently show this pattern.
Most investors only look at net income, which companies can manipulate through accounting rules. Cash flow is harder to fake. A ratio above 1.0 means every dollar of profit is backed by real cash.
Stock Details
Is it expensive?
Market Cap
17.40B
Trailing P/E Ratio
64.82
Forward P/E Ratio
29.56
PEG Ratio
29.56
19.91B
25.21
Price-to-Sales (TTM)
5.83
4.22
42.44
Is it profitable?
2.98B
Net Profit Margin (TTM)
8.98%
Gross Profit Margin
45.36%
Diluted EPS (TTM)
2.76
6.59%
Is it growing?
2.30%
2.90%
Is it risky?
1.13
63.11
2.61B
1.03
Who owns it?
12.13%
71.50%
0.00%
97.28M
27.60M
Does it pay?
1.54%
25.00%
Mar 31, 2026
--
How much cash?
521.20M
765.70M
256.06M
5.38
- Price (EOD)
- 178.90
- Percent Change
- -4.80 (2.61%)
- Previous Close
- 183.70
- Open
- 183.00
- Low
- 178.40
- High
- 184.90
52-Week Range Position (52WRP)
Below Average
Below Average
within its 1-year price range
€178.90
From 52W Low
+19.27%
From 52W High
-20.13%
Today
-2.61%
1Y Change
-7.71%
6M
€213.30
3M
€170.15
1M
€167.20
Today
€178.90
From 52W Low
+19.27%
From 52W High
-20.13%
Today
-2.61%
1Y Change
-7.71%
6M
€213.30
3M
€170.15
1M
€167.20
Today
€178.90
Below Average
within its 1-year price range
€178.90
Multi-Timeframe Analysis (MTA)
Divergence
Timeframes disagree. Short and long-term momentum are pulling in different directions, which historically signals higher uncertainty and potential turning points. As reflected in the Multi-Timeframe Analysis (MTA) below.
1M
+7.0%
3M
+5.1%
6M
-16.1%
1Y
-7.7%
Rate of Change (ROC)
Decelerating
Price has reversed, now rising vs its usual downtrend. As reflected in the ROC Momentum below, which compares recent monthly gain vs its 12-month average pace.
Relative Volume (RVOL)
Below Average
Fewer shares than usual are trading today. Low volume moves are less reliable. Price can drift without real conviction behind it. As reflected in the Relative Volume (RVOL) below.
- Name
- Sartorius Stedim Biotech S.A.
- Founded
- 1978
- CEO
- Rene Faber
- Employees
- 10,456
- Fiscal Year End
- Dec 31, 2025
- Address
Zone Industrielle Les Paluds
Aubagne
MI
13781
France
- GICS Classification
- Health Care›Health Care Equipment & Services›Health Care Equipment & Supplies
- Website
- www.sartorius.com
Related Heatmaps
CAC Next 20Index CAC Next 20 - CN20 |
SBF 120Index SBF 120 - PX4 |